Literature DB >> 20130217

The single IgG IL-1-related receptor controls TLR responses in differentiated human intestinal epithelial cells.

Mohammed A Khan1, Theodore S Steiner, Ho Pan Sham, Kirk S Bergstrom, Jingtian T Huang, Kiran Assi, Bill Salh, Isabella T Tai, Xiaoxia Li, Bruce A Vallance.   

Abstract

Intestinal epithelial cells (IECs) are constantly exposed to enteric microbes. Although IECs express TLRs that recognize bacterial products, the activation of these TLRs is strictly controlled through poorly understood mechanisms, producing a state of hyporesponsiveness and preventing unwanted inflammation. The single IgG IL-1-related receptor (Sigirr) is a negative regulator of TLRs that is expressed by IECs and was recently shown to inhibit experimental colitis. However, the importance of Sigirr in IEC hyporesponsiveness and its distribution within the human colon is unknown. In this study, we investigated the role of Sigirr in regulating epithelial-specific TLR responses and characterized its expression in colonic biopsy specimens. Transformed and nontransformed human IECs were cultured as monolayers. Transient gene silencing and stable overexpression of Sigirr was performed to assess innate IEC responses. Sigirr expression in human colonic biopsy specimens was examined by immunohistochemistry. Bacterial infection of IECs and exposure to flagellin transiently decreased Sigirr protein expression, concurrent with secretion of the neutrophil chemokine IL-8. Sigirr gene silencing augmented chemokine responses to bacterial flagellin, Pam3Cys, and the cytokine IL-1beta. Conversely, stable overexpression of Sigirr diminished NF-kappaB-mediated IL-8 responses to TLR ligands. We also found that Sigirr expression increased as IECs differentiated in culture. This observation was confirmed in biopsy sections, in which Sigirr expression within colonic crypts was prominent in IECs at the apex and diminished at the base. Our findings show that Sigirr broadly regulates innate responses in differentiated human IECs; therefore, it may modulate epithelial involvement in infectious and inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130217      PMCID: PMC3652552          DOI: 10.4049/jimmunol.0900021

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation.

Authors:  Patrick Laprise; Pierre Chailler; Mathieu Houde; Jean-François Beaulieu; Marie-Josée Boucher; Nathalie Rivard
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

2.  SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.

Authors:  David Wald; Jinzhong Qin; Zhendong Zhao; Youcun Qian; Mayumi Naramura; Liping Tian; Jennifer Towne; John E Sims; George R Stark; Xiaoxia Li
Journal:  Nat Immunol       Date:  2003-08-17       Impact factor: 25.606

3.  Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.

Authors:  M T Abreu; P Vora; E Faure; L S Thomas; E T Arnold; M Arditi
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Enteropathogenic Escherichia coli infection induces expression of the early growth response factor by activating mitogen-activated protein kinase cascades in epithelial cells.

Authors:  M de Grado; C M Rosenberger; A Gauthier; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Impairments in enzyme activity and biosynthesis of brush border-associated hydrolases in human intestinal Caco-2/TC7 cells infected by members of the Afa/Dr family of diffusely adhering Escherichia coli.

Authors:  I Peiffer; M F Bernet-Camard; M Rousset; A L Servin
Journal:  Cell Microbiol       Date:  2001-05       Impact factor: 3.715

6.  Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.

Authors:  Koji Hase; Lars Eckmann; John D Leopard; Nissi Varki; Martin F Kagnoff
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  The p38 mitogen-activated protein kinase regulates interleukin-1beta-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells.

Authors:  Kuljit Parhar; Andrew Ray; Urs Steinbrecher; Colleen Nelson; Baljinder Salh
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

8.  Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.

Authors:  E Cario; D K Podolsky
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Cellular differentiation causes a selective down-regulation of interleukin (IL)-1beta-mediated NF-kappaB activation and IL-8 gene expression in intestinal epithelial cells.

Authors:  U Böcker; A Schottelius; J M Watson; L Holt; L L Licato; D A Brenner; R B Sartor; C Jobin
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

10.  The role of the novel Th17 cytokine IL-26 in intestinal inflammation.

Authors:  J Dambacher; F Beigel; K Zitzmann; E N De Toni; B Göke; H M Diepolder; C J Auernhammer; S Brand
Journal:  Gut       Date:  2008-05-15       Impact factor: 23.059

View more
  15 in total

1.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection.

Authors:  Martin Stahl; Bruce A Vallance
Journal:  Gut Microbes       Date:  2015-04-01

3.  Intestinal epithelium-specific MyD88 signaling impacts host susceptibility to infectious colitis by promoting protective goblet cell and antimicrobial responses.

Authors:  Ganive Bhinder; Martin Stahl; Ho Pan Sham; Shauna M Crowley; Vijay Morampudi; Udit Dalwadi; Caixia Ma; Kevan Jacobson; Bruce A Vallance
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

Review 4.  Epithelial Toll-like receptors and their role in gut homeostasis and disease.

Authors:  Juan F Burgueño; Maria T Abreu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-26       Impact factor: 46.802

5.  The Helical Shape of Campylobacter jejuni Promotes In Vivo Pathogenesis by Aiding Transit through Intestinal Mucus and Colonization of Crypts.

Authors:  Martin Stahl; Emilisa Frirdich; Jenny Vermeulen; Yuliya Badayeva; Xiaoxia Li; Bruce A Vallance; Erin C Gaynor
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

6.  SIGIRR, a negative regulator of colon tumorigenesis.

Authors:  Junjie Zhao; Jarod Zepp; Katarzyna Bulek; Xiaoxia Li
Journal:  Drug Discov Today Dis Mech       Date:  2012-03-15

Review 7.  Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.

Authors:  Fiorella Biasi; Gabriella Leonarduzzi; Patricia I Oteiza; Giuseppe Poli
Journal:  Antioxid Redox Signal       Date:  2013-03-01       Impact factor: 8.401

8.  TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity.

Authors:  Federica Riva; Eduardo Bonavita; Elisa Barbati; Marta Muzio; Alberto Mantovani; Cecilia Garlanda
Journal:  Front Immunol       Date:  2012-10-29       Impact factor: 7.561

9.  SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells.

Authors:  Dan Li; Xin Zhang; Baiyi Chen
Journal:  BMC Immunol       Date:  2015-12-03       Impact factor: 3.615

Review 10.  Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.

Authors:  Martina Molgora; Domenico Supino; Alberto Mantovani; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.